welcome-institute-lig4-expert-interview1920x640
Whitepaper

Generating a clonal HAP1LIG4(-) Cas9(+) cell line – an expert interview

By incorporating a stably expressed Cas9 nuclease into Revvity’s HAP1 LIG4(-) cell line, the Sanger Institute has generated a new cell line that is highly amenable to efficient CRISPR/Cas9-mediated genomic modifications.

Read our interview with Dr. Sebastian Gerety, Principal Staff Scientist in the Human Genetics Program at the Sanger Institute, in which he discusses:

  • Why they developed this new HAP1 cell line
  • How leveraging the HAP1 LIG4(-) cell line developed with Revvity will help to accelerate the Sanger Institute’s research goals
  • How he envisions this new cell line impacting scientific discovery

For research use only. Not for use in diagnostic procedures.

To view the full content please answer a few questions

By submitting my personal data, I acknowledge that Revvity Inc. and its affiliates (“Company”) will process my personal data provided above consistent with the Company’s Privacy Policy available here.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Download Resource

Generating a clonal HAP1LIG4(-) Cas9(+) cell line – an expert interview

Download Whitepaper